Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:collaboratedWith |
gptkb:AstraZeneca
gptkb:Celgene gptkb:Amgen gptkb:Novartis |
| gptkbp:developed_drug |
gptkb:binimetinib
gptkb:encorafenib |
| gptkbp:focusesOn |
immunology
oncology small molecule drugs |
| gptkbp:founded |
1998
|
| gptkbp:founder |
gptkb:David_Snitman
gptkb:Kevin_Koch gptkb:Ronald_M._Squarer |
| gptkbp:headquarters_location |
gptkb:Boulder,_Colorado,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Array BioPharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Braftovi
gptkb:Mektovi |
| gptkbp:numberOfEmployees |
~300 (before acquisition)
|
| gptkbp:parentOrganization |
gptkb:Pfizer
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:status |
defunct (as independent company after 2019)
|
| gptkbp:stockSymbol |
ARRY
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.arraybiopharma.com/
|
| gptkbp:bfsParent |
gptkb:Pfizer
|
| gptkbp:bfsLayer |
4
|